Australia markets open in 2 hours 7 minutes

MacroGenics, Inc. (MGNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.5000+0.2900 (+9.03%)
At close: 04:00PM EDT
3.6000 +0.10 (+2.86%)
After hours: 05:11PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.2100
Bid3.3400 x 2200
Ask3.7300 x 1100
Day's range3.2000 - 3.5100
52-week range2.1300 - 22.6800
Avg. volume882,820
Market cap215.106M
Beta (5Y monthly)1.94
PE ratio (TTM)N/A
EPS (TTM)-3.5640
Earnings date31 Oct 2022 - 04 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est10.72
  • Motley Fool

    Why MacroGenics Stock Sank Today

    An analyst had a fresh new take on the company's prospects, and it wasn't all that positive.

  • GlobeNewswire

    MacroGenics to Participate in Upcoming Investor Conferences

    ROCKVILLE, MD, Sept. 02, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences in September 2022: Citi 17th Annual BioPharma Conference (Boston). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will participate in the Bispecifi

  • Simply Wall St.

    Brokers Are Upgrading Their Views On MacroGenics, Inc. (NASDAQ:MGNX) With These New Forecasts

    Shareholders in MacroGenics, Inc. ( NASDAQ:MGNX ) may be thrilled to learn that the analysts have just delivered a...